Similar articles

• Comparative analysis of electrophysiologic effect of metoprolol and disopyramide, acting alone or in combination in patients with supraventricular tachycardia and Wolff-Parkinson-White syndrome.

  Bobrov VA, Frolov AI, Mitchenko EI, Galichansky IV, Zinchenko YuV. Bobrov VA, et al. Rev Port Cardiol. 1994 Mar;13(3):221-5. Rev Port Cardiol. 1994. PMID: 8049089
• Preterm labor and accidental hemorrhage after disopyramide therapy in pregnancy. A case report.

  Abbi M, Kriplani A, Singh B. Abbi M, et al. J Reprod Med. 1999 Jul;44(7):653-5. J Reprod Med. 1999. PMID: 10442335
• Treatment of arrhythmias in the Wolff-Parkinson-White syndrome.

  Forester D. Forester D. Chest. 1979 Jun;75(6):745. doi: 10.1378/chest.75.6.745a. Chest. 1979. PMID: 436537 No abstract available.
• [Disopyramide phosphate: the electrophysiological mechanisms of its anti-arrhythmia action and its use in clinical practice].

  Grosu AA. Grosu AA. Kardiologiia. 1985 May;25(5):114-8. Kardiologiia. 1985. PMID: 3894756 Review. Russian. No abstract available.
• Pharmacologic management of supraventricular tachycardias in children. Part 1: Wolff-Parkinson-White and atrioventricular nodal reentry.

  Luedtke SA, Kuhn RJ, McCaffrey FM. Luedtke SA, et al. Ann Pharmacother. 1997 Oct;31(10):1227-43. doi: 10.1177/106002809703101016. Ann Pharmacother. 1997. PMID: 9337449 Review.